MedMira(OTC) MMIRF

Market Cap$28.07M

Since IPO (2012)-2%

5 Year-59%

1 Year-19%

1 Month-18%

$0.04

-2.44%

-0.00Today

MedMira last closing stock price
Metric	Price	Date
Last close	USD 0.04	2026-08-06

MedMira stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+3,233.33%	USD 0.00	2026-07-28
1 month	-17.86%	USD 0.05	2026-06-18
3 month	+230.58%	USD 0.01	2026-05-06
Year to date	+233.33%	USD 0.01	2025-12-31
1 year	-19.35%	USD 0.05	2025-07-28
3 year	-33.88%	USD 0.06	2023-07-17
5 year	-59%	USD 0.10	2021-08-06
Since inception	-2.44%	USD 0.04	2012-03-26

MedMira Financials at a Glance

Market Cap

$28.07M

Revenue (TTM)

CA$370.52K

Net Income (TTM)

-CA$2.71M

EPS (TTM)

-$0.00

P/E Ratio

-12.90

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$0.04

Volume

27,000

Open

$0.04

Price

$0.04

Volume

27,000

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.00 - $0.95

Estimated Earnings Date

Jun 30, 2026

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$0.04

Volume

27,000

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.00 - $0.95

Estimated Earnings Date

Jun 30, 2026

MMIRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedMira

MedMira Inc. is a biotechnology firm focused on the research, development, manufacturing, and distribution of rapid diagnostic solutions. The company operates globally, providing innovative testing products for various infectious diseases.

Products and Services

Reveal HIV tests for HIV-1 and HIV-2 antibodies
Multiplo series for multiplex testing of multiple infections
VYRA CoV2 for SARS-CoV-2 detection

Growth Outlook

Expansion into new markets in North America and Europe
Increased demand for rapid diagnostics post-pandemic
Strategic partnerships enhancing distribution capabilities

Financial Highlights

Recent quarterly revenue of CAD 241,108, showing growth potential
Trailing twelve months (TTM) revenue of CAD 1,000,000, indicating market interest
Operating expenses reflect ongoing investment in R&D and marketing

MedMira Inc. has established itself as a key player in the biotechnology sector, particularly in rapid diagnostics. The company's diverse product offerings cater to a wide range of infectious diseases, positioning it well for future growth. Recent financial data indicates a revenue increase, suggesting a positive trajectory as the demand for rapid testing solutions continues to rise. The strategic focus on expanding market reach and enhancing distribution networks further supports the company's growth potential. Investors may find MedMira's commitment to innovation and market expansion appealing as the healthcare landscape evolves.

AI Generated • Aug 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Hermes Hermes Chan

Website

www.medmira.com

Headquarters

Halifax, NS B3S 1B3, CA

MMIRF Financials

Key Financial Metrics (TTM)

Gross Margin

-448.07%

Operating Margin

-473.40%

Net Income Margin

-808.18%

Return on Equity

12.68%

Return on Capital

N/A

Return on Assets

-88.07%

Earnings Yield

-7.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.07M

Shares Outstanding

701.73M

Volume

27.00K

Avg. Volume

2.19K

Financials (TTM)

Gross Profit

-CA$238.70K

Operating Income

-CA$1.94M

EBITDA

-CA$1.66M

Operating Cash Flow

-CA$1.05M

Capital Expenditure

CA$4.00

Free Cash Flow

-CA$1.05M

Cash & ST Invst.

CA$0.00

Total Debt

CA$17.41M

MedMira Performance Analysis

MedMira annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-07-31	CAD 750,206	N/A
2023	2023-07-31	CAD 322,349	-57.0%
2024	2024-07-31	CAD 303,564	-5.8%
2025	2025-07-31	CAD 172,448	-43.2%

MedMira sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-07-31	-14.3%
Q1	2025-10-31	7.0%
Q2	2026-01-31	-54.7%
Q3	2026-04-30	882.5%

MedMira annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-07-31	CAD -0.00	N/A
2023	2023-07-31	CAD -0.00	38.1%
2024	2024-07-31	CAD -0.00	20.7%
2025	2025-07-31	CAD -0.00	34.3%

MedMira sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-07-31	-10.0%
Q1	2025-10-31	9.1%
Q2	2026-01-31	N/A
Q3	2026-04-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

CA$241.11K

+307.8%

Gross Profit

-CA$64.24K

-249.4%

Gross Margin

-26.64%

N/A

Market Cap

$28.07M

N/A

Market Cap/Employee

$539.79K

N/A

Employees

N/A

Net Income

-CA$483.50K

+50.8%

EBITDA

-CA$186.99K

+71.2%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

CA$0.00

-100.0%

Total Debt

CA$17.41M

+71.3%

Accounts Receivable

CA$1.30M

-1.2%

Inventory

CA$191.68K

-14.8%

Long Term Debt

CA$2.52M

-29.8%

Short Term Debt

CA$14.90M

+126.7%

Return on Assets

-88.07%

N/A

Return on Invested Capital

7.98%

N/A

Free Cash Flow

-CA$150.58K

+83.6%

Operating Cash Flow

-CA$150.58K

+83.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DTCFFDefence Therapeutics Inc.

DTCFFDefence Therapeutics Inc.$0.38+6.01%

SEOVFSernova Corp.

SEOVFSernova Corp.$0.08+0.00%

PVCTProvectus Biopharmaceuticals, Inc.

PVCTProvectus Biopharmaceuticals, Inc.$0.06+3.90%

RDGLVivos Inc.

RDGLVivos Inc.$0.05+0.48%

MDDVFMedical Developments International Limited

MDDVFMedical Developments International Limited$0.33+0.00%

TLTFFTheralase Technologies Inc.

TLTFFTheralase Technologies Inc.$0.14+4.09%

DSOLDrug Free Solution, Inc.

DSOLDrug Free Solution, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF

SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF$46.34-0.10%

NOKNokia

NOKNokia$10.03+0.03%

INTCIntel

INTCIntel$95.80+0.05%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$117.28+0.10%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.18-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.37+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.15-0.12%

Questions About MMIRF

What is the current price of MedMira?

MedMira is trading at $0.04 per share.

What is the 52-week range for MedMira?

Over the past 52 weeks, MedMira has traded between $0.00 and $0.95.

How much debt does MedMira have?

As of the most recent reporting period, MedMira reported total debt of CA$12.80M.

How much cash does MedMira have on hand?

MedMira reported CA$0.00 in cash and cash equivalents in its most recent financial results.

What is MedMira’s dividend yield?

MedMira does not currently have a dividend yield.

MedMira(OTC) MMIRF

MedMira Financials at a Glance

MMIRF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MedMira

MMIRF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MedMira Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MMIRF

What is the current price of MedMira?

What is the 52-week range for MedMira?

How much debt does MedMira have?

How much cash does MedMira have on hand?

What is MedMira’s dividend yield?

Premium Investing Services